We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
22 Oct 2020 - 25 Oct 2020
Virtual Venue
27 Oct 2020 - 31 Oct 2020
Virtual Venue
28 Oct 2020 - 30 Oct 2020
Virtual Venue

Image: Breath test developed for head and neck cancer diagnosis used a selected ion flow-tube mass spectrometer (Photo courtesy of Syft Technologies).

Breath Test Developed for Head and Neck Cancer Diagnosis

Breath testing is a noninvasive way to help doctors diagnose a number of conditions. By analyzing the breath, the physicians can measure the amount of certain gases, allowing doctors to arrive at a diagnosis quickly and accurately. More...
20 Oct 2020
Image: Breath test developed for head and neck cancer diagnosis used a selected ion flow-tube mass spectrometer (Photo courtesy of Syft Technologies).

Breath Test Developed for Head and Neck Cancer Diagnosis

Breath testing is a noninvasive way to help doctors diagnose a number of conditions. By analyzing the breath, the physicians can measure the amount of certain gases, allowing doctors to arrive at a diagnosis quickly and accurately. More...
20 Oct 2020
BIOHIT  Healthcare OY
Image: Schematic view of the placenta (Photo courtesy of Wikimedia Commons)

Analysis of Placental Cell Free DNA and RNA Predicts Gestational Complications

A recent paper revealed that circulating cell-free nucleic acids (DNA and RNA) shed from the placenta into the mother's blood during the first trimester of pregnancy could be used to predict potentially serious complications such as ischemic placental disease and gestational diabetes. More...
20 Oct 2020
Image: Glycated albumin levels in tears allows for noninvasive glucose testing (Photo courtesy of The University of Melbourne).

Glycated Albumin Levels in Tears Allow Noninvasive Glucose Testing

The glucose test helps determine if a person’s glucose level is too high or too low, which can indicate the presence of Type 2 diabetes and other medical conditions. The two most common types of glucose testing are the fasting plasma glucose test and the random plasma glucose test. More...
20 Oct 2020
Image: New Testing Process Could Make It Faster, Easier, And Less Expensive to Measure COVID-19 Antibody Levels (Photo courtesy of John W. Braun Jr., USAMRIID VIO)

New Testing Process Could Make It Faster, Easier, And Less Expensive to Measure COVID-19 Antibody Levels

Researchers testing alternative ways to measure COVID-19 antibody levels have developed a process that is faster, easier and less expensive to use on a large scale, and holds promise for accurately identifying potential donors who have the best chance of helping infected patients through convalescent plasma therapy. More...
20 Oct 2020
Image: Cong Zeng and Jack Evans were first authors of a paper describing a new assay that detects neutralizing antibodies against SARS-CoV-2 (Photo courtesy of Ohio State News)

New Lab Testing Procedure Specifically Identifies SARS-CoV-2 Neutralizing Antibodies

Scientists have developed a new lab testing procedure for the detection of antibodies against SARS-CoV-2 that gives results more quickly than existing assays and specifically identifies so-called “neutralizing” antibodies - those that protect by blocking infection of cells. More...
20 Oct 2020
Illustration

New Serology Assay Accelerates COVID-19 Research through Rapid Characterization of Immune Response to SARS-CoV-2 Antigens

A new SARS-CoV-2 multi-antigen assay for Simple Western offers quantitative characterization of patient serum or plasma derived human IgG antibodies reactive against recombinant Nucleocapsid protein (N), S1 receptor binding domain protein (RBD), S1 subunit full length, S2 subunit full length, and Spike (S1+S2) viral antigens within one 3-hour run. More...
20 Oct 2020
Copyright © 2000-2020 Globetech Media. All rights reserved.